Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Renovacor correlates $11m

Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.


Aug 15, 2019

Litera reads up on Doxly acquisition

Doxly has become the first exit for the IU Philanthropic Venture Fund after its acquisition by Litera Microsystems.

Aug 15, 2019

GraphPad scribbles down SnapGene

SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.

Aug 14, 2019

IURTC begins new era as IU Ventures

Indiana University's IURTC has become IU Ventures with a purview dedicated to administering the Philanthropic Venture Fund, angel network and entrepreneurial support services.

Aug 14, 2019

Landos lands $60m

Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.

Aug 14, 2019

Daily deal net: August 12, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 12, 2019

Carisma dazzles with extended series A

The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.

Aug 12, 2019

Corporates fuel Hydrogenious LOHC’s $19m round

Royal Vopak, Mitsubishi and Covestro helped the Erlangen–Nuremberg hydrogen storage technology spinout collect $19m in funding.

Aug 12, 2019

Daily deal net: August 9, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 9, 2019

Oxford Brain Diagnostics secures funding

Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.

Aug 9, 2019

Freiburg celebrates Cytena exit

Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.

Aug 9, 2019

MedWhat court strikes down more discovery objections

Motion-to-compel fines have been served to parties from Stanford University and Stanford-StartX Fund for blocking MedWhat's discovery request in the ongoing legal case.

Aug 9, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here